This annual workshop which started in 2007 has been held yearly .The first workshop was a joint effort of the Centre for AIDS research (CFAR) of Harvard Medical school and McCord Hospital (MH) ,Durban South Africa.

Professor Bruce Walker and Dr Raj Gandhi from CFAR jointly arranged this with Dr. Henry Sunpath and Dr Helga Holst from MH. 130 delegates attended the workshop in 2007 at the Athlone Riverside hotel in Durban. The workshop received great acclaim from the delegates for its relevance to the growing ART roll out programme in South Africa (SA).


The two-day interactive workshop will translate the latest evidence-based research and apply best practice models of care into good clinical practice, specifically for resource constrained areas


  1. Provide updates in the management of PLHIV with opportunistic infections, ART complications and treatment failure in resource-scarce settings.
  2. Educate on issues related to HIV in the pediatric population, the PMTCT programme and women.
  3. Develop experienced clinicians to work independently and serve as consultants in HIV medicine in different district and community health institutions, and
  4. create an opportunity for networking between HIV clinicians, academicians, researchers and policy makers.


  1. Infectious Diseases Unit of the Nelson Mandela School of Medicine (NRMSM) at the University of KwaZulu-Natal (UKZN)
  2. The South African HIV Clinicians Society (SAHIVCS) and


All major local institutions involved in HIV care and research over the last 6 years : UKZN Health Sciences department, Centre for programme in AIDS research South Africa (CAPRISA), Hospice Palliative Care Society (HPCS-SA), University of Wits and Cape Town, Right to Care, Kwa Zulu Natal Research Institute of HIV and TB (K-RITH). Several speakers have participated from leading US universities yearly.


  • Dr Henry Sunpath (MBBS; MFam Med; Dip HIVMan; MPH)
  • Mr. Nash Maharaj (NDM Accounting)
  • Dr. Christina Edwin (MBBS; DipHIVMan; MPhilPal Med)

The organizing committee:

  • Dr Henry Sunpath (chairperson)
  • Dr. Raj Gandhi (ID Unit Mass General Hospital, Harvard Medical School)
  • Prof MYS Moosa (ID Unit, NRMSM at UKZN)


The conference has attracted clinicians (nurses and doctors and pharmacists) from the private sector and public sector. Each year between 300 and 400 delegates have attended. Many medical aid administrators, pharmaceutical reps, heatlh department officials and paraclinical workers have also been part of the workshop.

List of the topics covered 2007 till 2015 will reflect the many challenges unique to the times from the initial ART roll out in SA to the current programme with about 2 million PLHIV on ART. The presentations are predominantly case based discussions.

  1. ART guidelines: when to start
  2. ART toxicities: management of lactic acidosis, peripheral neuropathy and lipodystrophy
  3. PMTCT guidelines: sd NVP and other regimens
  4. Paediatric ART challenges: treating younger children
  5. ART related anaemia
  6. Management of thrombocytopenia
  7. IRIS
  8. Renal failure in HIV
  9. Approach to CNS mass lesions
  10. Cryptococcal meningitis
  11. Challenges of a limited formulary in treating HBV infection
  12. Management of treatment failure: use of viral load monitoring
  13. Second line virological failures
  14. Adherence measures
  15. Role of traditional medicines
  16. HIV/TB and the liver
  17. Persistent diarrhea
  18. TB AND ART guidelines
  19. Hepatitis B treatment guidelines
  20. Tenofovir and renal failure
  21. New SA guidelines for treatment of pt with CD4 counts<350
  22. Early neurogognitive disorders
  23. When to start ART after OI diagnosis
  24. Operationalisation of inpatient ART
  25. Surgery in HIV patients
  26. Dermatological manifeatations
  27. Kaposis Sarcoma
  28. Revised PMTCT guidelines
  29. Metabolic complications of ART
  30. Genotypic resistance patterns of first and second line ART in SA
  31. Rheumatological manifestations in HIV
  32. Infection control in TB
  33. MDR and XDR TB
  34. Novel /pipeline TB drugs
  35. Rit Lopinavir and TB treatment
  36. Rapid diagnostics for TB
  37. Linkage to care in HIV
  38. Quality in Chronic disease management
  39. Management of immunological failure
  40. Palliative AIDS care
  41. Community based care for MDR/XDR TB
  42. NIMART
  43. Pharmacovigilance report
  44. Eradication of HIV/TB
  45. HIV in the ageing population
  46. Third line salvage ART
  47. Transmitted resistance
  48. Prevention of HIV: combined startegies
  49. Strengthening health systems
  50. Starting and sequencing ART
  51. Retention in care
  52. INH preventative therapy
  53. Expanding ART access
  54. Transmitted resistance
  55. Drug resistance workshops
  56. Workshops to reduce mortality among those presenting with advanced disease


1.Continued partnerships with current partners and extension of participation from other Southern African clinicians

2.Case based presentations that encourage participation and extended question and answer sessions

3.Support for DOH programme to build capacity among clinicians to manage patients who still present in advanced clinical disease. To build capacity to manage patients who fail virologically and those who may need third line ART.

4.To support systems to get PLHIV to engagae in care early and identify early warning indicators for virological failure and provide timely intervention

5.To continue to use the feedback from delegates yearly to build an academic and clinical programme of teaching 
through workshops.